What is the recommended schedule for the measles‑mumps‑rubella (MMR) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MMR Vaccine Schedule

Administer the first dose of MMR vaccine at 12-15 months of age and the second dose at 4-6 years of age. This two-dose schedule is the current standard recommendation endorsed by ACIP, AAP, and AAFP 1, 2.

Routine Childhood Schedule

First Dose

  • Timing: 12-15 months of age (minimum age: 12 months) 2
  • The vaccine can be given as early as 12 months, though seroconversion rates are slightly higher at 15 months (98%) versus 12 months (93-96%) 3
  • This difference has limited clinical significance because the second dose compensates for primary vaccine failure 3

Second Dose

  • Timing: 4-6 years of age (typically before kindergarten entry) 3, 1
  • Minimum interval: The second dose may be administered earlier than 4 years, provided at least 28 days (4 weeks) have elapsed since the first dose 4, 2
  • The primary benefit of the second dose is reducing the approximately 5% of children who fail to respond to the first dose due to primary vaccine failure 3

Special Situations

High-Risk Areas

In counties with large inner-city populations, recent measles outbreaks among unvaccinated preschoolers, or >5 measles cases among preschoolers in each of the last 5 years, administer the first dose at exactly 12 months rather than waiting until 15 months 3.

Early Vaccination (6-11 Months)

  • Infants vaccinated before 12 months (such as during outbreaks or before international travel) must receive two additional doses 2:
    • First routine dose at 12-15 months
    • Second dose at 4-6 years
  • This early dose does not count toward the two-dose series 2

Post-Exposure Prophylaxis

Administer MMR vaccine within 72 hours after measles exposure for unvaccinated individuals without contraindications 2.

Catch-Up Vaccination (≥7 Years)

For unvaccinated individuals aged ≥7 years, administer two doses separated by at least 28 days 4.

Adults

General Population

  • Born before 1957: Generally considered immune; no vaccination required 5
  • Born 1957 or later: Require at least one dose of MMR unless they have laboratory evidence of immunity or documented vaccination 5

High-Risk Adults (Require 2 Doses)

The following groups need two doses of MMR separated by at least 28 days 5:

  • Healthcare workers
  • College/post-secondary students
  • International travelers

Women of Childbearing Age

All women of childbearing age should have documented rubella immunity (one dose of MMR is sufficient for rubella protection). If no evidence of immunity exists and the woman is not pregnant, vaccinate immediately. If pregnant without immunity, vaccinate upon completion or termination of pregnancy before hospital discharge 5, 3, 5.

Key Clinical Considerations

Common Pitfall: Do not restart the vaccine series regardless of time elapsed between doses. If the schedule is interrupted, simply continue where it was stopped 4.

Documentation: Acceptable evidence of immunity includes laboratory confirmation of disease or immunity, or documented age-appropriate vaccination—but physician-diagnosed disease is no longer accepted as evidence of immunity for measles and mumps 6.

HIV-Infected Children: Should receive MMR at 12 months if they do not have current severe immunosuppression 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.